http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101670115-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6cb4ab729c5c94a203059e5d3f32dbeb |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-385 |
| filingDate | 2009-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_405ce859047ab1295c6fe4a019d7ca14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_660d2116f5f6eb39ec7460ffd9a0b7d3 |
| publicationDate | 2010-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-101670115-A |
| titleOfInvention | Compound of heparanase and heat shock protein, preparation method and applications thereof |
| abstract | The invention discloses a compound of heparanase and heat shock protein, a preparation method and applications thereof. The compound is bonded by the heparan and heat shock protein 110 at a non-covalent bond. The heparan has an amino acid sequence indicated in SEQ ID No.2 and the heat shock protein 110 has an amino acid sequence indicated in SEQ ID No.6. The compound can induce strong antitumor immunity, needs no adjuvant, is not limited by MHC when being applied in homogeneity, has wide tumor therapy spectrum, has simple preparation method, can be used for preparing tumor vaccine and has excellent development and application prospect in the field of tumor immunotherapy. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103562218-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103562218-B |
| priorityDate | 2009-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 96.